Genetic associations in diabetic nephropathy

Clinical and Experimental Nephrology

Volumn 18, Issue 2, 2014, Pages 197-200

  Mooyaart, Antien L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Complex disease; Diabetic nephropathy; Genetics; Meta analysis

Indexed keywords

DIABETIC NEPHROPATHY; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC VARIABILITY; HEREDITY; HUMAN; HYPOTHESIS; META ANALYSIS (TOPIC); PROBABILITY; REVIEW; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS;

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84899934370     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0874-9     Document Type: Review

References (23)

1. Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group. Diabetes Care. 1990;13:427-33.
2. Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med. 1987;317:1390-8. (Pubitemid 18052346)
3. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:438-43. (Pubitemid 20220945)
4. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320:1161-5. (Pubitemid 19124296)
5. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33:177-82. (Pubitemid 36177070)
6. Zeggini E, Ioannidis JP. Meta-analysis in genome-wide association studies. Pharmacogenomics. 2009;10:191-201.
7. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434-42. (Pubitemid 38443646)
8. Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science. 2008;322:881-8.
9. Mooyaart AL, Valk EJ, van Es LA, et al. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia. 2011;54: 544-53.
10. Rosario RF, Prabhakar S. Lipids and diabetic nephropathy. Curr Diab Rep. 2006;6:455-62. (Pubitemid 44896405)
11. Molendijk ML, Bus BA, Spinhoven P, Kaimatzoglou A, Oude Voshaar RC, Penninx BW, van IJzendoorn MH, Elzinga BM. A systematic review and meta-analysis on the association between BDNF val(66)met and hippocampal volume-a genuine effect or a winners curse? Am J Med Genet B Neuropsychiatr Genet. 2012;159B(6):731-40. doi:10.1002/ajmg.b.32078.
12. Williams WW, Salem RM, McKnight AJ, et al. Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy. Diabetes. 2012;61: 2187-94.
13. Welcome Trust Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-78.
14. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124.
15. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9:356-69. (Pubitemid 351556063)
16. Janssens AC, Moonesinghe R, Yang Q, Steyerberg EW, van Duijn CM, Khoury MJ. The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med. 2007;9:528-35. (Pubitemid 47282041)
17. Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ. 2009;338:b880. doi:10.1136/bmj.b880.:b880.
18. Lyssenko V, Jonsson A, Almgren P et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008;359:2220-32.
19. Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet. 2012;13:135-45.
20. Payami H, Kaye J, Heston LL, Bird TD, Schellenberg GD. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993;342:738.
21. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 2004;305:869-72. (Pubitemid 39038422)
22. Romeo S, Pennacchio LA, Fu Y, et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet. 2007;39:513-6. (Pubitemid 46514768)
23. Goldstein DB. Common genetic variation and human traits. N Engl J Med. 2009;360:1696-8.